Vaishali Pharma Limited (NSE:VAISHALI)

Vaishali Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	10.46	17.11	14.57	5.29	11.62	3.13
Cash & Short-Term Investments	10.46	17.11	14.57	5.29	11.62	3.13
Cash Growth	-8.48%	17.41%	175.35%	-54.48%	270.76%	10.69%
Accounts Receivable	512.21	467.17	494.28	536.1	585.05	667.31
Other Receivables	-	4.66	5.13	3.72	3.18	4.84
Receivables	512.21	471.83	499.41	539.82	588.23	672.14
Inventory	18.97	48.1	3.8	30.5	6.29	5.88
Prepaid Expenses	-	0.57	0.43	0.53	0.69	0.05
Other Current Assets	572.37	507.24	227	150.57	157.45	131.74
Total Current Assets	1,114	1,045	745.2	726.71	764.29	812.95
Property, Plant & Equipment	14.08	11.61	14.55	17.98	9.04	9.71
Long-Term Investments	54.34	17.53	17.53	16.38	10.82	10.81
Other Intangible Assets	8.22	9.23	8.02	8.56	7.69	2.94
Long-Term Deferred Tax Assets	1.41	1.84	1.76	1.43	1.61	1.48
Other Long-Term Assets	27.18	13.4	12.51	17.92	22.81	23.37
Total Assets	1,219	1,098	799.56	788.98	816.24	861.26
Accounts Payable	303.61	271.45	193.89	179.97	283.81	405.37
Accrued Expenses	2.05	-0.37	13.15	17.42	21.15	26.52
Short-Term Debt	-	43.04	76.19	73.42	166.94	116.24
Current Portion of Long-Term Debt	81.23	31.6	13.92	10.94	9.62	19.17
Current Portion of Leases	2.66	2.35	6.46	1.91	0.12	0.49
Current Income Taxes Payable	8.77	-	-	19.46	12.72	3.77
Current Unearned Revenue	-	52.46	27.21	17.56	25.02	21.07
Other Current Liabilities	72.19	-	-	-0	-	-
Total Current Liabilities	470.5	400.53	330.82	320.68	519.37	592.63
Long-Term Debt	69.74	41.95	35.98	52.27	31.06	40.33
Long-Term Leases	2.38	4.24	2.36	8.82	0.38	2.26
Pension & Post-Retirement Benefits	2.78	2.57	2	1.89	1.89	1.85
Other Long-Term Liabilities	0	-	-	0	0	0
Total Liabilities	545.4	449.29	371.16	383.66	552.7	637.07
Common Stock	260.92	260.92	107.19	105.46	105.46	105.46
Additional Paid-In Capital	-	229.11	100.02	80.73	80.98	82.02
Retained Earnings	-	157.29	149.11	141.92	75.89	35.65
Comprehensive Income & Other	412.89	1.84	72.08	77.21	1.22	1.05
Shareholders' Equity	673.82	649.16	428.4	405.32	263.54	224.19
Total Liabilities & Equity	1,219	1,098	799.56	788.98	816.24	861.26
Total Debt	156.01	123.18	134.92	147.36	208.11	178.5
Net Cash (Debt)	-145.55	-106.08	-120.35	-142.07	-196.49	-175.36
Net Cash Per Share	-1.12	-0.84	-1.12	-1.27	-1.86	-1.66
Filing Date Shares Outstanding	131.83	130.46	107.19	105.46	105.46	105.46
Total Common Shares Outstanding	131.83	130.46	107.19	105.46	105.46	105.46
Working Capital	643.5	644.31	414.38	406.04	244.92	220.33
Book Value Per Share	5.11	4.98	4.00	3.84	2.50	2.13
Tangible Book Value	665.6	639.93	420.38	396.76	255.85	221.25
Tangible Book Value Per Share	5.05	4.91	3.92	3.76	2.43	2.10
Buildings	-	7.25	7.25	7.25	7.25	7.25
Machinery	-	12.14	11.56	11.14	10.11	7.46

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.